Vanguard Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Buy |
4,191,854
+236,755
| +6% | +$2.66M | ﹤0.01% | 2148 |
|
|
2025
Q1 | $18.1M | Sell |
3,955,099
-51,535
| -1% | -$236K | ﹤0.01% | 2557 |
|
|
2024
Q4 | $22.6M | Buy |
4,006,634
+1,473
| +0% | +$8.31K | ﹤0.01% | 2527 |
|
|
2024
Q3 | $19.4M | Sell |
4,005,161
-1,258,348
| -24% | -$6.09M | ﹤0.01% | 2602 |
|
|
2024
Q2 | $25.7M | Sell |
5,263,509
-1,067,803
| -17% | -$5.21M | ﹤0.01% | 2451 |
|
|
2024
Q1 | $84.1M | Buy |
6,331,312
+859,382
| +16% | +$11.4M | ﹤0.01% | 1950 |
|
|
2023
Q4 | $76.3M | Buy |
5,471,930
+638,962
| +13% | +$8.91M | ﹤0.01% | 1996 |
|
|
2023
Q3 | $64.1M | Buy |
4,832,968
+741,753
| +18% | +$9.84M | ﹤0.01% | 2017 |
|
|
2023
Q2 | $76.7M | Buy |
4,091,215
+212,365
| +5% | +$3.98M | ﹤0.01% | 2001 |
|
|
2023
Q1 | $55.9M | Buy |
3,878,850
+66,826
| +2% | +$964K | ﹤0.01% | 2124 |
|
|
2022
Q4 | $73.8M | Buy |
3,812,024
+153,212
| +4% | +$2.96M | ﹤0.01% | 1973 |
|
|
2022
Q3 | $126M | Buy |
3,658,812
+1,316,619
| +56% | +$45.2M | ﹤0.01% | 1657 |
|
|
2022
Q2 | $35.8M | Buy |
2,342,193
+23,418
| +1% | +$358K | ﹤0.01% | 2348 |
|
|
2022
Q1 | $52.9M | Buy |
2,318,775
+954,554
| +70% | +$21.8M | ﹤0.01% | 2277 |
|
|
2021
Q4 | $50.3M | Buy |
1,364,221
+81,679
| +6% | +$3.01M | ﹤0.01% | 2349 |
|
|
2021
Q3 | $60.3M | Buy |
1,282,542
+1,217,542
| +1,873% | +$57.2M | ﹤0.01% | 2260 |
|
|
2021
Q2 | $3.92M | Buy |
+65,000
| New | +$3.92M | ﹤0.01% | 3715 |
|